Researchers examine why SSRIs take time to work
Selective serotonin reuptake inhibitors (SSRIs) have different acute and long-term effects, but the reasons are unclear. Researchers may have solved this mystery by showing that serotonergic neurons release both serotonin and glutamate, thereby transmitting a dual signal with behaviourally distinct effects.
Writing in Trends in Cognitive Sciences (online, 17 December 2014), the team notes that the serotonergic component is immediately amplified following SSRI administration, whereas the glutamate component is suppressed in the acute phase and normalises only after several days of SSRI therapy.
The initial reduction in glutamate could explain why SSRIs have a delayed onset of therapeutic effect in depression, say the authors. It could also lead to new drug targets aimed at bridging the delayed action and increasing therapeutic efficacy.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067467
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now